A ternary photocatalyst combining carbon quantum dots, an iron polyoxometalate and a zinc cadmium sulfide semiconductor ...
Relay Therapeutics is approaching a pivotal clinical catalyst with the March 16th zovegalisib Phase 1/2 data readout at ESMO TAT. RLAY’s financials show improved operational efficiency, with reduced R ...
Relay Orbital Hybridization Boosts Lithium–Oxygen Battery Catalysis. Schematic illustration of phosphorus-doped MnMoO₄ hollow nanospheres enabling “relay orbital hybridization.” Internal Mo–P orbital ...
Relay catalysis connects multiple catalytic reactions so that the product of one step becomes the reactant of the next. This approach can improve efficiency, increase selectivity, and reduce energy ...
Relay Therapeutics is upgraded to Outperform with a $14 price target, driven by optimism for zovegalisib in PIK3CA-mutant HR+/HER2- metastatic breast cancer. Zovegalisib’s mutant-selective PI3Kα ...
Silylium ions, formally R₃Si⁺ species paired with weakly coordinating anions, have emerged as exceptionally powerful electrophilic catalysts in a diverse array of organic transformations. Generated by ...
Relay announced a $50 million growth investment from General Catalyst through its Customer Value Fund. The financing is designed to help Relay accelerate customer acquisition while continuing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results